SAN FRANCISCO—A “guided missile” approach to treating metastatic, castration-resistant, taxane-refractory prostate cancer demonstrated success at the 2014 ASCO Genitourinary Cancers Symposium. Daniel Petrylak MD of Yale University Medical Center in New Haven CT discussed the clinical potential arising from his …
Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology Annual Meeting, May 30-June 3, 2008, Chicago
In this edition:
1. Zoledronic …
Scientific Editors: George Canellos, Pat Price, Gordon McVie, Gianni Bonadonna
In this edition:
Bevacizumab and Survival in Metastatic Breast Cancer
Source: N Engl J Med 357:26
George Canellos, Dana-Farber Cancer Institute, Boston
Progresson-free survival, but not overall survival, was …
REFERENCE: J Clin Oncol 24:5680-5686
GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston
Using postmenopausal estrogen replacement before the diagnosis of colorectal cancer was associated with better cancer-specific and
 Lorie Hughes |  Rachel Ellsworth |  Rowan Chlebowski |  Victor Vogel |
REFERENCE: Abstract: 29
LORIE HUGHES, The Hope Center, Cartersville GA
The intergroup study E-5194 has found that local excision without radiation
 David Cameron |  Martine Piccart |  Eric Van Cutsem |
 Jim Cassidy |  Volker Heinemann |
REFERENCE: ESMO 2006, Abstract: 141O
David Cameron, Western General Hospital, Edinburgh
COMMENT: Martine Piccart, Jules
 Gordon McVie |  Martine Piccart |  Bella Kaufman |  Jean-Yves Douillard |
GORDON MCVIE, European Institute of Oncology, Milan
In Istanbul, Gordon McVie gave his opinion about the achievements of the 2006 European Society for Medical Oncology Congress. He added his